Evidence map›Paper›PMID 42365507›Full record

ArticleAntimicrobial agents and chemotherapy2026

A community-based One Health approach to the pandemic dynamics of

Aiko Maeda, Toyotaka Sato, Akira Fukuda, Torahiko Okubo, Masaru Usui, Mana Tohyama, Jirachaya Toyting-Hiraishi, Naoyuki Tsukamoto, Akio Suzuki, Yuuji Hoshino and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Aiko MaedaLaboratory of Veterinary Hygiene, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.ORCID 0009-0003-4071-2555
Toyotaka SatoLaboratory of Veterinary Hygiene, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.ORCID 0000-0001-7223-1623
Akira FukudaFood Microbiology and Food Safety Unit, Division of Preventive Veterinary Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.ORCID 0000-0003-3645-4867
Torahiko OkuboFaculty of Health Sciences, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-3194-5862
Masaru UsuiFood Microbiology and Food Safety Unit, Division of Preventive Veterinary Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Mana TohyamaLaboratory of Veterinary Hygiene, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Jirachaya Toyting-HiraishiLaboratory of Veterinary Hygiene, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Naoyuki TsukamotoSapporo Mirai Laboratory, Sapporo, Japan.
Akio SuzukiLaboratory of Veterinary Hygiene, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Yuuji HoshinoKikusui Small Animal Hospital, Sapporo, Japan.
Shingo TorigoeAinosato Animal Hospital, Sapporo, Japan.
Keiichiro SakakibaraNorth Animal Clinic, Sapporo, Japan.
Satoshi TamaiAnicom Specialty Medical Institute Inc., Tokyo, Japan.
Tooru TachibanaHokko Animal Hospital, Sapporo, Japan.
Satoshi TakahashiDepartment of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Shin-Ichi YokotaDivision of Microbiology, Department of Infectious Diseases, Sapporo Medical University School of Medicine, Sapporo, Japan.
Motohiro HoriuchiLaboratory of Veterinary Hygiene, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.

Funding

Japan Agency for Medical Research and Development JP20ak0101118h0002, JP23gm1610012h0001, JP22ama121039, JP23ama121039, JP22ama121053Japan Science and Technology Agency JPMJSP2119Japan Science and Technology Agency ST211004JOJapan Society for the Promotion of Science JP21H03622, JP22K19416, JP25H01077
6 · The paper itself

Abstract

Large-scale genomic studies have advanced our understanding of the global dissemination of antimicrobial-resistant (AMR) bacteria, yet most have been limited by inconsistent sampling periods, heterogeneous geographic coverage, and weak epidemiological linkages among isolates. Consequently, the fine-scale processes underlying the establishment and maintenance of AMR pandemics remain unclear. To address these limitations, we established a rigorously controlled community- and household-integrated One Health framework that incorporates human, animal, and environmental reservoirs within a single urban area and unified sampling period, focusing on the pandemic fluoroquinolone-resistant (FQ-R)

Indexed as

Escherichia coliEscherichia coli InfectionsAnimalsAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialFluoroquinolonesGenome, BacterialHumansJapanMicrobial Sensitivity TestsOne HealthPandemicsAnti-Bacterial AgentsFluoroquinolonesantimicrobial resistanceEscherichia colifluoroquinoloneOne HealthST131

Identifiers

PMID42365507
PMCPMC13435643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.